| Followers | 3165 |
| Posts | 209870 |
| Boards Moderated | 1 |
| Alias Born | 02/04/2004 |
Thursday, February 21, 2019 6:30:04 PM
Toxic funders like EMA are always trying to squeeze OTC PubCo's for additional interest payment monies and when they get told to screw off they file these types of frivolous suits thinking the over-whelming majority of OTC CEO's are broke asses they will beat in court due to the majority of OTC CEO's not even being able to afford an attorney.
So without seeing any additional details on what EMA is alleging in their suit...and the fact that EMA had already been 1 of the dilutive funders selling convertible notes all last year(as the conversions in your copied/pasted conversion table clearly reflect)...my immediate guess is that Felcia decided to try to intimidate VYST with an unreasonable phony baloney interest payment demand on top of their already converted note...and CEO Steve Rotman told her to screw off...so now she's running to court to file another frivolous "interest payment" suit which VYST's CEO is clearly more than ready, willing and able to fight...otherwise the suit wouldn't even have been filed right!
So without seeing any additional details on what EMA is alleging in their suit...and the fact that EMA had already been 1 of the dilutive funders selling convertible notes all last year(as the conversions in your copied/pasted conversion table clearly reflect)...my immediate guess is that Felcia decided to try to intimidate VYST with an unreasonable phony baloney interest payment demand on top of their already converted note...and CEO Steve Rotman told her to screw off...so now she's running to court to file another frivolous "interest payment" suit which VYST's CEO is clearly more than ready, willing and able to fight...otherwise the suit wouldn't even have been filed right!
Recent VYST News
- Vystar Plans Dividend Spin Off of RXAIR and Related Brands Following R3alm, Inc. Transaction • GlobeNewswire Inc. • 04/27/2026 12:00:00 PM
- Vystar and R3alm Launch R3alm.com Following Strategic Transaction • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc. • GlobeNewswire Inc. • 04/20/2026 01:22:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 06:25:19 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/30/2026 03:33:28 PM
- Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform • GlobeNewswire Inc. • 02/18/2026 02:30:00 PM
- Vystar Enters Final Testing of Breakthrough Dialysis Water Filtration Technology • GlobeNewswire Inc. • 01/29/2026 03:40:00 PM
- Vystar to Acquire Stake in GoPaid and Partner with Capital R3alm to Launch R3alm Oracle and Collectibles Platform • GlobeNewswire Inc. • 01/27/2026 03:57:10 PM
- Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles • GlobeNewswire Inc. • 01/08/2026 04:40:38 PM
- Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded. • GlobeNewswire Inc. • 12/22/2025 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 05:59:16 PM
- Incubator Stock Review Initiates Coverage on Vystar • GlobeNewswire Inc. • 10/24/2025 02:05:00 PM
- Vystar’s Vytex® Cloud Bed-in-a-Box Available for Sale • GlobeNewswire Inc. • 10/17/2025 12:30:00 PM
- Vystar® to restart sales of Vytex® Cloud Bed-in-a-Box • GlobeNewswire Inc. • 09/12/2025 01:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2025 04:16:02 PM

